I don't care about whether they report results or if they miss deadlines for reporting. That's all this article is talking about. But only studies that are pre

I don't care about whether they report results or if they miss deadlines for reporting. That's all this article is talking about. But only studies that are pre-registered should be considered when approving a drug, treatment, or device, and any incomplete studies (that is pre-registered but not reported for any reasons) should be treated as "all the patients died", and all individual researchers on the preregistration should be appropriately tainted for future consideration of studies in which they participate. The related story in the article, "Gaming the system" does report on this: > .. a recent study ... examined 19 drugs approved by the FDA in 2015. In only 10 cases were all the trials provided to FDA for its decisions registered on ClinicalTrials.gov. This is unacceptable.